{
  "id": "enwiki-001366566680",
  "slug": "enteromix",
  "title": "EnteroMix",
  "qid": "",
  "lead": "EnteroMix (Russian: ЭнтероМикс) is an experimental cancer immunotherapy under development in Russia. According to its developers, EnteroMix is a mixture of four oncolytic viruses—replication-competent human enteroviruses including Coxsackievirus A21, Echovirus 7, Enterovirus B75, and a modified derivative of a Sabin poliovirus vaccine strain—and is administered intravenously. , it is in Phase I clinical trials, which primarily assess safety, dosage, and preliminary tolerability, rather than effectiveness. In May 2026, the trial was formally registered on ClinicalTrials.gov (identifier NCT07584668) under the investigational code EM-I-2024, providing the first internationally verifiable record of the ongoing Phase I study. EnteroMix gained widespread international media attention in late 2025, despite lack of publications in peer-reviewed journals internationally. Social media claims of high efficacy, imminent availability, and even ‘cure’ status have been shown to be exaggerated and misleading by independent fact-checking organizations.",
  "body": "EnteroMix (Russian: ЭнтероМикс) is an experimental cancer immunotherapy under development in Russia. According to its developers, EnteroMix is a mixture of four oncolytic viruses—replication-competent human enteroviruses including Coxsackievirus A21, Echovirus 7, Enterovirus B75, and a modified derivative of a Sabin poliovirus vaccine strain—and is administered intravenously. , it is in Phase I clinical trials, which primarily assess safety, dosage, and preliminary tolerability, rather than effectiveness. In May 2026, the trial was formally registered on ClinicalTrials.gov (identifier NCT07584668) under the investigational code EM-I-2024, providing the first internationally verifiable record of the ongoing Phase I study. EnteroMix gained widespread international media attention in late 2025, despite lack of publications in peer-reviewed journals internationally. Social media claims of high efficacy, imminent availability, and even ‘cure’ status have been shown to be exaggerated and misleading by independent fact-checking organizations.",
  "categories": [
    "104341943",
    "113832365",
    "22985424",
    "23603337",
    "23703189",
    "26220375",
    "62579678",
    "63706498",
    "75737880",
    "84215243"
  ],
  "license": "CC BY-SA 4.0",
  "source_uri": "https://en.wikipedia.org/w/index.php?oldid=1366566680",
  "content_hash": "",
  "created_at": null,
  "updated_at": 1785260449.0,
  "claims": [],
  "contradictions": [],
  "confidence": 0.6,
  "csl": {
    "id": "enwiki-001366566680",
    "type": "webpage",
    "title": "EnteroMix",
    "author": [
      {
        "family": "Anticloud FZ LLE",
        "literal": "Anticloud FZ LLE"
      }
    ],
    "container-title": "encyclopegia.org",
    "publisher": "Anticloud FZ LLE",
    "publisher-place": "Dubai, United Arab Emirates",
    "URL": "https://encyclopegia.org/a/enteromix",
    "issued": {
      "date-parts": [
        [
          2026,
          11,
          20
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          2026,
          11,
          20
        ]
      ]
    },
    "license": "CC BY-SA 4.0",
    "DOI": "eo1:enwiki-001366566680",
    "isBasedOn": "https://en.wikipedia.org/w/index.php?oldid=1366566680",
    "note": "Immutable snapshot enwiki-001366566680"
  }
}